Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes

January 2007

Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes.

It's true that thiazides increase the risk of hyperglycemia and new-onset diabetes.

But a new analysis of the large ALLHAT hypertension trial shows that this does NOT translate into a higher risk of CV events or death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote